Impact of a 1-year lifestyle modification program on plasma lipoprotein and PCSK9 concentrations in patients with coronary artery disease

J Clin Lipidol. 2016 Nov-Dec;10(6):1353-1361. doi: 10.1016/j.jacl.2016.08.014. Epub 2016 Sep 2.

Abstract

Background: Patients with coronary artery disease (CAD) are characterized by an impaired cardiometabolic risk profile including high levels of atherogenic apolipoprotein (apo) B-containing lipoprotein levels. Genetic studies have highlighted a critical role for proprotein convertase subtilisin/kexin type 9 (PCSK9) in lipoprotein metabolism and CAD risk.

Objective: To determine whether improving dietary quality and increasing physical activity levels improve parameters of the cardiometabolic risk profile such as plasma apoB and PCSK9 levels in patients with CAD.

Methods: We recruited 86 men aged between 39 and 80 years (82 of them on statins) undergoing coronary artery bypass graft (CABG) surgery. These patients participated in a 1-year lifestyle modification program aiming at achieving a minimum of 150 minutes/week of physical activity and improving diet quality by following dietary guidelines. We used magnetic resonance imaging to measure visceral adipose tissue and a modified Bruce protocol to measure fitness levels before and after the intervention.

Results: Plasma apoB and low-density lipoprotein cholesterol levels were not modified by the intervention (-3.0%, P = .08 and 1.3%, P = .56, respectively), whereas non-HDL cholesterol decreased by 4.5% (P = .04) and triglycerides by 13% (P = .002). In contrast, PCSK9 levels increased by 5.2% after the intervention (P = .05). HDL cholesterol and apolipoprotein A-I levels also increased (+12%, P < .0001 and + 6%, P < .0001, respectively). PCSK9 levels increased with improvements in fitness (r = 0.23, P = .04) and visceral fat mobilization (r = -0.23, P = .04).

Conclusion: In post-CABG patients, a lifestyle modification program lead to significant improvements in some parameters of the lipoprotein profile but unexpectedly increased plasma PCSK9 levels.

Keywords: Coronary artery disease; Ectopic fat; Lifestyle; Lipoproteins; PCSK9.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Abdominal Fat / diagnostic imaging
  • Adult
  • Aged
  • Aged, 80 and over
  • Apolipoprotein A-I / blood
  • Apolipoproteins B / blood
  • Cholesterol, HDL / blood
  • Cholesterol, LDL / blood
  • Coronary Artery Bypass
  • Coronary Artery Disease / pathology*
  • Coronary Artery Disease / surgery
  • Exercise
  • Humans
  • Life Style
  • Lipoproteins / blood*
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Program Evaluation*
  • Proprotein Convertase 9 / blood*

Substances

  • Apolipoprotein A-I
  • Apolipoproteins B
  • Cholesterol, HDL
  • Cholesterol, LDL
  • Lipoproteins
  • Proprotein Convertase 9